Macrophage and Natural Killer cell molecular targets

The term Macrophage and Natural Killer (NK) cell molecular targets refers to a broad category of receptors, enzymes, and signaling molecules expressed on the surface or within these specific innate immune cells. Macrophages are myeloid cells responsible for phagocytosis and antigen presentation, often targeted via molecules like Colony-stimulating factor 1 receptor (CSF1R) or CD47 to modulate the tumor microenvironment (Source: National Cancer Institute). Natural Killer cells are cytotoxic lymphocytes that identify and kill virally infected or transformed cells, with therapeutic strategies often focusing on activating receptors like NKG2D or inhibitory receptors like Killer-cell immunoglobulin-like receptors (KIRs) (Source: PubMed, PMID: 33503338). Because this entry represents a functional group of diverse proteins rather than a single canonical molecule, it is classified as an incorrect target designation for specific drug-receptor modeling. Therapeutic intervention in this space generally aims to either enhance the anti-tumor activity of these cells or suppress their pro-inflammatory roles in chronic disease (Source: Nature Reviews Drug Discovery).

Other names

Myeloid and NK cell surface markersInnate immune cell targets

Not applicable as this is a broad category of targets rather than a single molecular entity.